Evidence map›Paper›PMID 33282737›Full record

ArticleFrontiers in oncology2020

Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-Care.

Lee Curtin, Paula Whitmire, Cassandra R Rickertsen, Gina L Mazza, Peter Canoll, Sandra K Johnston, Maciej M Mrugala, Kristin R Swanson, Leland S Hu

Abstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Fractal-Based Morphometrics of Glioblastoma.Advances in neurobiology · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lee CurtinMathematical NeuroOncology Lab, Precision Neurotherapeutics Innovation Program, Department of Neurologic Surgery, Mayo Clinic, Arizona, AZ, United States.
Paula WhitmireMathematical NeuroOncology Lab, Precision Neurotherapeutics Innovation Program, Department of Neurologic Surgery, Mayo Clinic, Arizona, AZ, United States.
Cassandra R RickertsenMathematical NeuroOncology Lab, Precision Neurotherapeutics Innovation Program, Department of Neurologic Surgery, Mayo Clinic, Arizona, AZ, United States.
Gina L MazzaDepartment of Health Sciences Research, Mayo Clinic, Arizona, AZ, United States.
Peter CanollDepartment of Pathology and Cell Biology, Columbia University, New York, NY, United States.
Sandra K JohnstonMathematical NeuroOncology Lab, Precision Neurotherapeutics Innovation Program, Department of Neurologic Surgery, Mayo Clinic, Arizona, AZ, United States.
Maciej M MrugalaDepartment of Neurology, Mayo Clinic, Arizona, AZ, United States.
Kristin R SwansonMathematical NeuroOncology Lab, Precision Neurotherapeutics Innovation Program, Department of Neurologic Surgery, Mayo Clinic, Arizona, AZ, United States.
Leland S HuDepartment of Radiology, Mayo Clinic, Arizona, AZ, United States.

Funding

"Research Supplement to Promote Diversity in Health-Related Research", as part of Moffitt PS-OC, "Cancer as a Complex adaptive System"U54CA193489 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI ANDERSON, ALEXANDER ROBERTSON ALLAN, GATENBY, ROBERT A · 2015 to 2020
$12.5M
Trans Network ProjectU54CA210180 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WHITE, FOREST M · 2016 to 2020
$10.2M
The Physi(ologi)cal Microenvironment and its Role in Tumor Invasion and MetastaseU54CA143970 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GATENBY, ROBERT A · 2009 to 2014
$9.3M
Patient-specific predictive modeling that integrates advanced cancer imagingR01CA164371 · NCI · UNIVERSITY OF WASHINGTON · PI KINAHAN, PAUL E., SWANSON, KRISTIN R · 2011 to 2015
$4.5M
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in GlioblastomaU01CA220378 · NCI · MAYO CLINIC ARIZONA · PI HU, LELAND, SWANSON, KRISTIN R · 2017 to 2021
$4.3M
Novel Tools for Evaluation and Prediction of Radiotherapy Response in IndividualR01NS060752 · NINDS · UNIVERSITY OF WASHINGTON · PI SWANSON, KRISTIN R · 2009 to 2013
$1.6M
Multi-site Validation and Application of a Consensus DSC MRI ProtocolR01CA221938 · NCI · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI BOXERMAN, JERROLD L, HU, LELAND · 2018 to 2020
$738k
MRI-based mapping of regional genomic diversity in GlioblastomaR21NS082609 · NINDS · MAYO CLINIC ARIZONA · PI HU, LELAND · 2013 to 2014
$525k
NCI NIH HHS R01 CA164371NCI NIH HHS U01 CA220378NCI NIH HHS U54 CA143970NCI NIH HHS U54 CA193489NCI NIH HHS U54 CA210180NINDS NIH HHS R01 NS060752NINDS NIH HHS R21 NS082609
6 · The paper itself

Abstract

Glioblastoma (GBM) is the most aggressive primary brain tumor and can have cystic components, identifiable through magnetic resonance imaging (MRI). Previous studies suggest that cysts occur in 7-23% of GBMs and report mixed results regarding their prognostic impact. Using our retrospective cohort of 493 patients with first-diagnosis GBM, we carried out an exploratory analysis on this potential link between cystic GBM and survival. Using pretreatment MRIs, we manually identified 88 patients with GBM that had a significant cystic component at presentation and 405 patients that did not. Patients with cystic GBM had significantly longer overall survival and were significantly younger at presentation. Within patients who received the current standard of care (SOC) (

Indexed as

cystglioblastomaprognosissex-specificstandard-of-caresurvival

Identifiers

PMID33282737
PMCPMC7705378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.